Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
Journalists
Submit Release
December 30, 2008
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Websites.
 
All Press Releases for December 30, 2008 Subscribe to this News Feed    
 

Ariadne Provides Pathway Studio® Interoperability with Illumina's New GenomeStudio Software

Ariadne announces the completion of a key partner program with Illumina Inc., to provide advanced integration and interpretation capabilities for data generated from their iScan and BeadArray Reader platforms. The coupling of Ariadne's Pathway Studio® to Illumina's next generation software, GenomeStudio™ Data Analysis Software, provides researchers with a state-of-the-art toolset to quickly analyze expression data for physiological changes, cell signaling and other significant biological changes.

Rockville, MD (PRWEB) December 30, 2008 -- Ariadne announces the completion of a key partner program with Illumina Inc., to provide advanced integration and interpretation capabilities for data generated from their iScan and BeadArray Reader platforms. The coupling of Ariadne's Pathway Studio® to Illumina's next generation software, GenomeStudio™ Data Analysis Software, provides researchers with a state-of-the-art toolset to quickly analyze expression data for physiological changes, cell signaling and other significant biological changes.

Ilya Mazo Ph.D, President of Ariadne, said, "Ariadne has always supported analysis of Illumina data. The integration of Pathway Studio with Illumina's GenomeStudio Software improves the analysis workflow by rapidly characterizing experimental data into meaningful results helping biologists develop new experiments and hypotheses. With the addition of advanced data analysis and pathway creation provided by Pathway Studio, Illumina's customers will achieve a significant research advantage by simplifying the transition from statistical data analysis to biological interpretation. We see a strong demand for this interoperability with academics, pharmaceutical companies, and with plant genomic companies. Ariadne is excited about this accomplishment and looks forward to expanding this interoperability with Illumina's additional experimental technologies."

"Ariadne is the first to offer a plug-in with our newly launched GenomeStudio Software program. By providing a graphical representation of Illumina's microarray data, Pathway Studio offers researchers a unique way to complete advanced downstream analysis," said Omoshile Clement, Ph.D., Senior Product Manager of Software Informatics at Illumina. "Illumina and its software partners continue to improve tools that aid in the interpretation of data across multiple applications."

Pathway Studio provides academic and commercial clients with analytical capabilities for experimental data that provide biological context and mechanistic interpretation. Proprietary algorithms analyze experimental data to perform functional analysis, identify regulated pathways, or discover new biological networks. This bench-top application provides scientists a direct method to interpret their data, to formulate new hypotheses and to design new experiments.

For more information about Pathway Studio, please contact Ariadne at 240-453-6296 or www.ariadnegenomics.com.

About ARIADNE:
ARIADNE (www.ariadnegenomics.com) Pathway Studio software is used worldwide as a comprehensive solution for analysis and searching of pathways and molecular interaction information. Ariadne offers desktop and enterprise editions of Pathway Studio which are supported by several commercial and publicly available molecular interaction databases including ResNet Mammalian, ResNet Plant, and Prolexys HyNet. Pathway Studio is powered by MedScan* Technology, which researchers can use to edit and enhance database content from the current literature and from experimental data.
*Patent pending

###

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
NATALIA ALEXANDROVA
Ariadne
240-453-6296
Email us Here
ATTACHED FILES

Ariadne Provides Pathway Studio Interoperability with Illumina's New GenomeStudio Software

Ariadne Provides Pathway Studio Interoperability with Illumina's New GenomeStudio Software
Ariadne Provides Pathway StudioŽ Interoperability with Illumina's New GenomeStudio Software - Press Release

Sub-Network Enrichment Analysis

Sub-Network Enrichment Analysis
Sub-Network Enrichment Analysis

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright